>_ QFI Terminal
Terminal › Stocks › CLOV

Clover Health Investments, Corp. (CLOV) Stock

Healthcare · Medical - Healthcare Plans · US
$4.73 -1.05%
Last updated Oct 23, 2026 00:42 UTC

CLOV Key Statistics

Market Cap$2.51B
P/E (TTM)-113.70
P/S (TTM)1.01
P/B (TTM)6.59
Revenue (TTM)$2.48B
EPS (TTM)$-0.04
Dividend Yield—
ROE (TTM)-5.38%
Net Margin-0.74%
Gross Margin18.57%
52W High$5.59
52W Low$1.58
Analyst ViewHold
Price Target$5.50
Employees724
Volume3,189,699

About Clover Health Investments, Corp.

Clover Health Investments, Corp. is a U.S.-based firm specializing in Medicare Advantage insurance. The company leverages its proprietary software platform, the Clover Assistant, to provide both Preferred Provider Organization (PPO) and Health Maintenance Organization (HMO) health plans for individuals eligible for Medicare. In addition to its insurance operations, Clover Health also engages in non-insurance-related business ventures. The company was established in 2014 and its main office is located in Franklin, Tennessee.

CEO: Andrew Toy. Company website

CLOV — Frequently Asked Questions

What is the CLOV stock price today?

Clover Health Investments, Corp. (CLOV) trades at $4.73, down 1.05% on the day, as of Oct 23, 2026 00:42 UTC.

What is Clover Health Investments, Corp.'s market cap?

Clover Health Investments, Corp. has a market capitalisation of $2.51B, calculated from the live CLOV share price and shares outstanding.

What is the P/E ratio of CLOV?

CLOV has no meaningful price-to-earnings ratio: Clover Health Investments, Corp. lost $0.04 per share over the last twelve months, and a P/E is only defined on positive earnings.

How much revenue does Clover Health Investments, Corp. make?

Clover Health Investments, Corp. generated revenue of $2.48B over the trailing twelve months, which puts the stock at 1.01 times sales.

What is the 52-week range for CLOV?

CLOV has traded between $1.58 and $5.59 over the past 52 weeks, and the last price is 15.4% below that high.

Is Clover Health Investments, Corp. profitable?

No. Clover Health Investments, Corp. is loss-making, with a net margin of -0.74% over the trailing twelve months.

What is the analyst price target for CLOV?

Wall Street analysts rate CLOV Hold, with an average price target of $5.50, 16.3% above the current price.

What sector is Clover Health Investments, Corp. in?

Clover Health Investments, Corp. is classified under the Healthcare sector and the Medical - Healthcare Plans industry, and is domiciled in US.

Who is the CEO of Clover Health Investments, Corp.?

Andrew Toy is the chief executive of Clover Health Investments, Corp., which employs 724 people.

Where can I track CLOV in real time?

QFI Terminal shows CLOV with live charts, full financials, the options chain with gamma exposure, institutional ownership and analyst ratings on one screen. The free plan has no time limit and asks for no card.

See CLOV live in QFI Terminal

Interactive charts, full financials, options chain, gamma exposure, ownership and analyst ratings, all in one institutional-grade terminal.

Open CLOV in Terminal See plans

Medical - Healthcare Plans stocks

UNH UnitedHealth Group Incorporated CVS CVS Health Corp. CI Cigna Corporation ELV Elevance Health Inc. CNC Centene Corp. HUM Humana Inc. MOH Molina Healthcare, Inc. OSCR Oscar Health, Inc. PGNY Progyny, Inc.

More Healthcare stocks

MCK McKesson Corporation COR Cencora, Inc. NVO Novo Nordisk A/S CAH Cardinal Health, Inc. JNJ Johnson & Johnson LLY Eli Lilly and Company HCA HCA Healthcare, Inc. MRK Merck & Co., Inc. ABBV AbbVie Inc. PFE Pfizer Inc. AZN AstraZeneca PLC NVS Novartis AG BMY Bristol-Myers Squibb Company SNY Sanofi ABT Abbott Laboratories TMO Thermo Fisher Scientific Inc. AMGN Amgen Inc. MDT Medtronic Plc GSK GSK plc GILD Gilead Sciences, Inc. MDLN Medline Inc. SYK Stryker Corporation DHR Danaher Corporation CYH Community Health Systems, Inc. THC Tenet Healthcare Corporation BSX Boston Scientific Corporation BDX Becton, Dickinson and Company GEHC GE HealthCare Technologies Inc. FMS Fresenius Medical Care AG & Co. KGaA UHS Universal Health Services, Inc. TEVA Teva Pharmaceutical Industries Limited

ETFs holding CLOV

IWM iShares Russell 2000 ETF 0.07% SCHA Schwab U.S. Small-Cap ETF 0.05% SCHB Schwab U.S. Broad Market ETF 0.00% VTI Vanguard Morningstar Total Stock Market ETF 0.00%

Largest institutional holders of CLOV

BlackRock, Inc. BLK 35,106,965 shares
VANGUARD CAPITAL MANAGEMENT LLC 18,037,661 shares
GEODE CAPITAL MANAGEMENT, LLC 10,846,066 shares
STATE STREET CORP STT 10,180,337 shares
Nuveen, LLC 6,291,699 shares
Sixth Street Partners Management Company, L.P. 5,521,188 shares
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 5,521,188 shares
VANGUARD PORTFOLIO MANAGEMENT LLC 4,470,452 shares
NORTHERN TRUST CORP NTRS 3,772,600 shares